These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 36342000)

  • 21. The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report.
    Lumbreras J; Subias M; Espinosa N; Ferrer JM; Arjona E; Rodríguez de Córdoba S
    Front Immunol; 2020; 11():1348. PubMed ID: 32765494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical hemolytic uremic syndrome in first trimester pregnancy successfully treated with eculizumab.
    Andries G; Karass M; Yandrapalli S; Linder K; Liu D; Nelson J; Pawar R; Chugh S
    Exp Hematol Oncol; 2017; 6():4. PubMed ID: 28101432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eculizumab therapy on a patient with co-existent lupus nephritis and C3 mutation-related atypical haemolytic uremic syndrome: a case report.
    Kim MJ; Lee H; Kim YH; Jin SY; Kim HJ; Oh D; Jeon JS
    BMC Nephrol; 2021 Mar; 22(1):86. PubMed ID: 33691638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose-6-Phosphate Dehydrogenase Deficiency Mimicking Atypical Hemolytic Uremic Syndrome.
    Walsh PR; Johnson S; Brocklebank V; Salvatore J; Christian M; Kavanagh D
    Am J Kidney Dis; 2018 Feb; 71(2):287-290. PubMed ID: 29248304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature.
    Saleem M; Shaikh S; Hu Z; Pozzi N; Java A
    Front Immunol; 2022; 13():909503. PubMed ID: 35720299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation.
    Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L
    Front Immunol; 2022; 13():1008294. PubMed ID: 36451836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
    Sridharan M; Go RS; Willrich MAV
    J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
    Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
    Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
    Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atypical hemolytic uremic syndrome].
    Blasco Pelicano M; Rodríguez de Córdoba S; Campistol Plana JM
    Med Clin (Barc); 2015 Nov; 145(10):438-45. PubMed ID: 25433773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry.
    Halimi JM; Al-Dakkak I; Anokhina K; Ardissino G; Licht C; Lim WH; Massart A; Schaefer F; Walle JV; Rondeau E
    J Nephrol; 2023 Apr; 36(3):817-828. PubMed ID: 36152218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis.
    Fakhouri F; Scully M; Ardissino G; Al-Dakkak I; Miller B; Rondeau E
    J Nephrol; 2021 Oct; 34(5):1581-1590. PubMed ID: 33826112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Plasma Exchange and Eculizumab.
    Kannan L
    Am J Case Rep; 2023 Apr; 24():e938896. PubMed ID: 37120715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case series: coronavirus disease 2019 infection as a precipitant of atypical hemolytic uremic syndrome: two case reports.
    Kurian CJ; French Z; Kukulich P; Lankiewicz M; Ghimire S; Maarouf OH; Rizk S; Rhoades R
    J Med Case Rep; 2021 Dec; 15(1):587. PubMed ID: 34903272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19: a trigger for severe thrombotic microangiopathy in a patient with complement gene variant.
    Pinte L; Sorohan BM; Prohászka Z; Gherghiceanu M; Băicuş C
    Rom J Intern Med; 2022 Jun; 60(2):138-142. PubMed ID: 34997957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
    Sharma S; Pradhan M; Meyers KE; Le Palma K; Laskin BL
    Clin Nephrol; 2015 Sep; 84(3):181-5. PubMed ID: 25816809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review.
    Manenti L; Rossi GM; Pisani I; Gentile M; Fontana F; Pilato FP; Delsante M; Ricco F; Mignani R; Mele C; Bresin E; Fiaccadori E
    J Nephrol; 2022 May; 35(4):1091-1100. PubMed ID: 34757577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complement Factor I Gene Variant in an Atypical Hemolytic Uremic Syndrome Triggered by Hypereosinophilia Syndrome.
    Banjongjit A; Kittanamongkolchai W; Kanjanabuch T
    Nephron; 2023; 147(11):701-706. PubMed ID: 37611541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.
    Malgaj Vrečko M; Aleš Rigler A; Večerić-Haler Ž
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An extremely rare splice site mutation in the gene encoding complement factor I in a patient with atypical hemolytic uremic syndrome.
    Ipe TS; Lim J; Reyes MA; Ero M; Leveque C; Lewis B; Kain J
    J Clin Apher; 2017 Dec; 32(6):584-588. PubMed ID: 28455885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.